We spend 80–95% of our lives breathing in more than 350 ft3 of indoor air every day. Up to ten times more polluted than outside air, indoor air can be teeming with viruses, bacteria, VOCs, fungal spores, and allergens.
WellAir Announces Acquisition of UV Innovators and Appointment of President & CEO Todd Pope
Read the press release.
Our portable medical-grade air disinfection devices use patented NanoStrikeTM technology to inactivate airborne pathogens and neutralize VOCs. Available in three sizes.
Installed in existing or new HVAC systems, our Plasma Air devices use UL 2998 validated bipolar ionization to reduce particulate matter, odors, viruses, and bacteria.
NuvaWave is an instant UVC device proven to disinfect surfaces against deadly pathogens in one second with its targeted UVC light and portable, handheld design.
Novaerus, Plasma Air and NuvaWave products have been shown in more than 40 laboratory tests to reduce viruses, bacteria, particulate, mold, and VOCs in indoor air.
The WellAir Medical Advisory Board (MAB) develops, educates and supports innovation in a multi-disciplinary approach to improve the healthiness of indoor environments.
The board brings together a diverse group of leading public health, environmental and medical experts. The WellAir MAB will study and advise upon the advancement of indoor air and surface quality with an emphasis on improving respiratory, immunological, oncologic and general public health outcomes.